INTRODUCTION
Mycobacterium abscessus (M. abscessus) is one of the rapidly growing mycobacterial species and it is found in soil, dust and water. M. abscessus was first described by Moore and Frerichs in 1953 , and these organisms are ubiquitous in the environment 1 . It is an uncommon cause of human diseases, but it can cause skin and soft tissue infection after skin injury following inoculation, minor trauma or surgery 1, 2 . The single most important factor for determining the course and prognosis of a M. abscessus infection is the underlying immune status of the host 3 .
Several cases of skin and soft tissue infection caused by M. abscessus have been reported in Korea [4] [5] [6] [7] [8] .
CASE REPORT
A 71-year-old woman visited our hospital with a week history of multiple painful erythematous swollen nodules and plaques on the left forearm ( Fig. 1 ). She was a diabetes patient and had taken an injection of unknown material for managing the chronic pain of the affected arm. In addition, she had taken oral steroid by herself for about two years for treating her osteoarthritis. The laboratory examinations to identify bacteria or fungus in the pus specimen from the patient revealed negative results. Acid fast bacilli (AFB) staining and polymerase chain reaction (PCR) analysis for mycobacteria (M. tuberculosis and mycobacterium other than tuberculosis) were also performed on the pus specimen and the results were negative.
Culture from the pus specimen on 3% Ogawa media showed yellowish colonies. The colonies were identified as M. abscessus by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP, PRA) with using the novel region of the rpo B gene obtained from the Korean Institute of Tuberculosis, Seoul, Korea (Fig. 2) . The mycobacterial species showed resistance to isoniazid, rifampicin, streptomycin, ethombutol, kanamycin, capreomycin, prothionamaide, cycloserine, pyrazinamide and ofloxacin. The histological findings showed polymorphonuclear microabscesses and granulomatous inflammation in the dermis and subcutaneous fat tissue (Fig. 3, 4) . No acid fast bacilli were observed by AFB staining. Gram staining and PAS staining were also negative. Culture and PCR analysis for mycobacteria were also performed on the tissue specimen and the results were negative. Curettage and drainage, followed by 6 months of oral clarithromycin administration induced the complete healing of the lesions. After a 6 month remission period, similar skin lesions developed on the left forearm (Fig. 5) .
The patient had received acupuncture procedures on the left forearm to control pain of the arm. It was estimated that the skin lesions appeared 2 weeks after the initial acupuncture session. Any mycologic study from the pus specimen of new skin lesions revealed negative result. Skin biopsy showed granulomatous inflammation, but AFB staining, culture and PCR analysis from the tissue specimen showed negative results for M. abscessus. Considering that the clinical and pathologic features of the new infection were similar to those of the previous infection, we assumed that the lesions were caused by the recurrence or reinfection of M. abscessus and we administered oral clarithromycin for 3 months. The skin lesions showed improvement after a month of treatment.
DISCUSSION
The nomenclature of rapidly growing atypical mycobacteria has recently changed with the advent of biochemical techniques, which allow species to be more accurately identified. In the past they were simply identified as belonging to the 'M. fortuitum complex'. Now, with using DNA homology studies, four separate species have been identified as M. fortuitum, M. peregrinum, M. chelonae and M. abscessus. Each of them is associated with different disease syndromes, and each of them has a distinct anti-microbial susceptibility pattern 9 .
M. abscessus was first described by Moore is not clear for how long treatment should be continued, but as with other mycobacterial infections, many authors feel that 6 months of treatment should be given, and especially for immunocompromised patients 3 . Our treatment started with 2nd generation cephalosporin and surgical drainage before the identification of the causative agent, but the lesion showed no improvement and then it became rather aggravated. Oral clarithromycin was administrated after we identified M. abscessus, and the skin lesion showed improvement after a month of treatment. Although rare, an atypical mycobacterial infection should be considered for the case of a local cutaneous infection that's resistant to antibiotic therapy, and especially if this is seen on an immunocompromised patient.
